KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Net Cash Flow (2016 - 2025)

Amgen (AMGN) has 17 years of Net Cash Flow data on record, last reported at -$316.0 million in Q4 2025.

  • For Q4 2025, Net Cash Flow fell 110.67% year-over-year to -$316.0 million; the TTM value through Dec 2025 reached -$2.8 billion, down 376.38%, while the annual FY2025 figure was -$2.8 billion, 376.38% down from the prior year.
  • Net Cash Flow reached -$316.0 million in Q4 2025 per AMGN's latest filing, down from $1.4 billion in the prior quarter.
  • Across five years, Net Cash Flow topped out at $23.9 billion in Q1 2023 and bottomed at -$23.8 billion in Q4 2023.
  • Average Net Cash Flow over 5 years is $143.2 million, with a median of -$303.0 million recorded in 2024.
  • Peak YoY movement for Net Cash Flow: surged 9305.17% in 2021, then tumbled 1170.53% in 2023.
  • A 5-year view of Net Cash Flow shows it stood at -$4.0 billion in 2021, then soared by 52.94% to -$1.9 billion in 2022, then crashed by 1170.53% to -$23.8 billion in 2023, then surged by 112.45% to $3.0 billion in 2024, then crashed by 110.67% to -$316.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were -$316.0 million in Q4 2025, $1.4 billion in Q3 2025, and -$782.0 million in Q2 2025.